Medical Management of Uterine Fibroids
Medical Management of Uterine Fibroids is organized by The Society of Obstetricians and Gynaecologists of Canada (SOGC).
Credits:
You may claim a maximum of 3.0 hours for this course
Description:
The medical management of uterine fibroids is an evolving practice. As novel therapies are introduced, clinical practice guidance has been updated to provide evidence-based recommendations on the evolving role of these agents in clinical practice. This online course reviews the role of medical therapy in the management of uterine fibroids. The Society of Obstetricians and Gynaecologists of Canada (SOGC) provides guidance for The Management of Uterine Leiomyomas (SOGC CPG #318). Additional SOGC guidance of relevance to this topic includes: Abnormal Uterine Bleeding in Pre-Menopausal Women, and The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility. “Until recently, medical management options for uterine leiomyomas have been of limited value because of their moderate efficacy and/or associated adverse effects. Novel therapies at the receptor and gene levels have emerged or are undergoing investigation and may eventually offer better long-term management options.” (SOGC Clinical Practice Guideline #318)
Additional details will be posted as soon as they are available.